Open Label Study in Adolescents and Children With Myotonic Disorders
Status:
Recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
This is an open-label, multi-centre, single arm, interventional study to describe the
steady-state PK, safety, and efficacy of mexiletine in paediatric patients (6 to <18 years of
age) with myotonic disorders.